HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level

[1]  M. Zeier,et al.  Is There a Need for Additional DQ Matching? , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[2]  G. Klintmalm,et al.  Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts , 2017, Transplantation.

[3]  G. Gerken,et al.  Immunosuppression with mTOR inhibitors prevents the development of donor‐specific antibodies after liver transplant , 2017, Clinical transplantation.

[4]  N. Kamar,et al.  Donor-specific antibodies and liver transplantation. , 2016, Human immunology.

[5]  G. Gerken,et al.  Diagnostics and treatment of a severe humoral rejection after liver transplantation: donor-specific antibodies as a still underestimated cause of graft failure , 2016, Zeitschrift für Gastroenterologie.

[6]  T. Fehr,et al.  Donor-specific antibodies require preactivated immune system to harm renal transplant , 2016, EBioMedicine.

[7]  T. Ueno,et al.  Impact of Donor-Specific Antibodies on Graft Fibrosis After Pediatric Living Donor Liver Transplantation for Biliary Atresia. , 2016, Transplantation proceedings.

[8]  J. Joh,et al.  Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation. , 2016, Transplantation proceedings.

[9]  L. Rostaing,et al.  De novo donor‐specific anti‐HLA antibodies mediated rejection in liver‐transplant patients , 2015, Transplant international : official journal of the European Society for Organ Transplantation.

[10]  E. Reed,et al.  Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation , 2015, Transplantation.

[11]  G. Klintmalm,et al.  Impact of IgG3 Subclass and C1q‐Fixing Donor‐Specific HLA Alloantibodies on Rejection and Survival in Liver Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  S. Jordan,et al.  Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches , 2014, Current opinion in organ transplantation.

[13]  L. Rostaing,et al.  Prevalence, Incidence and Risk Factors for Donor‐Specific Anti‐HLA Antibodies in Maintenance Liver Transplant Patients , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  G. Klintmalm,et al.  Antibody‐mediated rejection as a contributor to previously unexplained early liver allograft loss , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  G. Klintmalm,et al.  Preformed class II donor‐specific antibodies are associated with an increased risk of early rejection after liver transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[16]  G. Klintmalm,et al.  De Novo Donor‐Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  I. Popescu,et al.  Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[18]  M. Stegall,et al.  Prevalence, Course and Impact of HLA Donor‐Specific Antibodies in Liver Transplantation in the First Year , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  C. O’mahony,et al.  Liver transplantation in autoimmune liver diseases. , 2011, Best practice & research. Clinical gastroenterology.

[20]  G. Klintmalm,et al.  High Mean Fluorescence Intensity Donor‐Specific Anti‐HLA Antibodies Associated With Chronic Rejection Postliver Transplant , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  K. Kokko,et al.  Donor‐Directed MHC Class I Antibody Is Preferentially Cleared from Sensitized Recipients of Combined Liver/Kidney Transplants , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  J. Woosley,et al.  Liver allograft antibody‐mediated rejection with demonstration of sinusoidal C4d staining and circulating donor‐specific antibodies , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[23]  J. Pirsch,et al.  The Significance of Donor‐Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  Walter K. Kremers,et al.  Baseline Donor‐Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  R. Wiesner,et al.  Long‐term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the national institute of diabetes and digestive and kidney diseases liver transplantation database , 2008, Hepatology.

[26]  E. Paz-Artal,et al.  Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[27]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[28]  T. Starzl,et al.  A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies , 1992, Hepatology.

[29]  T. Starzl,et al.  A histometric analysis of chronically rejected human liver allografts: Insights into the mechanisms of bile duct loss: Direct immunologic and ischemic factors , 1989, Hepatology.

[30]  Prof. Dr. med. Gustav Steinhoff,et al.  ANALYSIS OF SEQUENTIAL CHANGES IN MAJOR HISTOCOMPATIBILITY COMPLEX EXPRESSION IN HUMAN LIVER GRAFTS AFTER TRANSPLANTATION , 1988, Transplantation.